PARP inhibitors and synthetic lethality in ovarian cancer

Date 25 November 2018
Event ESMO Asia 2018 Congress
Session Advances in targeted therapy in gynaecological cancer
Topics Ovarian Cancer
Personalised/Precision Medicine
Presenter Eric Pujade-Lauraine
Authors E. Pujade-Lauraine
  • -, Groupe hospitalier Hôtel Dieu (AP-HP), 75181 - Paris/FR